Iovance Biotherapeutics (IOVA) Return on Capital Employed (2016 - 2025)
Historic Return on Capital Employed for Iovance Biotherapeutics (IOVA) over the last 10 years, with Q3 2025 value amounting to 0.53%.
- Iovance Biotherapeutics' Return on Capital Employed changed N/A to 0.53% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.53%, marking a year-over-year change of. This contributed to the annual value of 0.55% for FY2024, which is N/A changed from last year.
- Per Iovance Biotherapeutics' latest filing, its Return on Capital Employed stood at 0.53% for Q3 2025.
- In the past 5 years, Iovance Biotherapeutics' Return on Capital Employed registered a high of 0.42% during Q2 2023, and its lowest value of 0.65% during Q4 2023.
- Its 3-year average for Return on Capital Employed is 0.52%, with a median of 0.52% in 2025.
- As far as peak fluctuations go, Iovance Biotherapeutics' Return on Capital Employed tumbled by -2100bps in 2024, and later surged by 1400bps in 2025.
- Iovance Biotherapeutics' Return on Capital Employed (Quarter) stood at 0.65% in 2023, then rose by 3bps to 0.63% in 2024, then increased by 15bps to 0.53% in 2025.
- Its last three reported values are 0.53% in Q3 2025, 0.51% for Q2 2025, and 0.49% during Q1 2025.